{
    "eid": "2-s2.0-85169303749",
    "title": "Practical use of apomorphine infusion in Parkinson\u2019s disease: lessons from the TOLEDO study and clinical experience",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Psychiatry and Mental Health",
            "@code": "2738",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Biological Psychiatry",
            "@code": "2803",
            "@abbrev": "NEUR"
        }
    ],
    "keywords": [
        "Apomorphine infusion",
        "Clinical practice",
        "Parkinson\u2019s disease"
    ],
    "authors": [
        "Tove Henriksen",
        "Regina Katzenschlager",
        "Roongroj Bhidayasiri",
        "Harry Staines",
        "Donna Lockhart",
        "Andrew Lees"
    ],
    "citedby-count": 0,
    "ref-count": 33,
    "ref-list": [
        "Pharmacological insights into the use of apomorphine in Parkinson\u2019s disease: clinical relevance",
        "The many faces of apomorphine: lessons from the past and challenges for the future",
        "Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therapy",
        "Practical management of adverse events related to apomorphine therapy",
        "Long-term apomorphine infusion users versus short-term users: an international dual-center analysis of the reasons for discontinuing therapy",
        "Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients",
        "Unmet needs in Parkinson's disease: new horizons in a changing landscape",
        "Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study",
        "Quality of life in Parkinson's disease improved by apomorphine pump: the OPTIPUMP cohort study",
        "Effect of Chronic domperidone use on QT interval: a large single center study",
        "International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease",
        "Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study",
        "The apomorphine test",
        "Continuous subcutaneous apomorphine infusion in Parkinson's disease: a single-center, long-term follow-up study of the causes for discontinuation",
        "Effects of continuous subcutaneous apomorphine infusion in Parkinson's disease without cognitive impairment on motor, cognitive, psychiatric symptoms and quality of life",
        "Apomorphine-pharmacological properties and clinical trials in Parkinson's disease",
        "Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges",
        "Apomorphine subcutaneous infusion in patients with Parkinson\u2019s disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial",
        "Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: results of the open-label phase of the TOLEDO study",
        "Implications of dopaminergic medication withdrawal in Parkinson's disease",
        "Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients",
        "Long-term effect of apomorphine infusion in advanced Parkinson's disease: a real-life study",
        "Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: a systematic review and meta-analysis of observational studies",
        "Early factors for predicting discontinuation to subcutaneous Apomorphine infusion in Parkinson's disease: a prospective analysis of the Thai Apomorphine Registry",
        "Apomorphine: an underutilized therapy for Parkinson's disease",
        "Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease",
        "Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors",
        "Continuous subcutaneous apomorphine infusion in advanced Parkinson's disease: 10-year experience with 230 patients",
        "Infusion therapies and development of impulse control disorders in advanced Parkinson disease: clinical experience after 3 years' follow-up",
        "Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations",
        "Dopamine agonist withdrawal syndrome: a comprehensive review"
    ],
    "affiliation": [
        {
            "affiliation-city": "Copenhagen",
            "@id": "60025840",
            "affilname": "Bispebjerg Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025840",
            "affiliation-country": "Denmark"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "London",
            "@id": "60019953",
            "affilname": "UCL Queen Square Institute of Neurology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019953",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Vienna",
            "@id": "128843336",
            "affilname": "Klinik Donaustadt",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/128843336",
            "affiliation-country": "Austria"
        },
        {
            "affiliation-city": "Balmullo",
            "@id": "126437988",
            "affilname": "Sigma Statistical Services",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126437988",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Reading",
            "@id": "121384770",
            "affilname": "Britannia Pharmaceuticals Limited",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/121384770",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "113736755",
            "affilname": "Academy of Science",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/113736755",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Britannia Pharmaceuticals Ltd"
    ]
}